About This Role
As the Executive Medical Director for Early Clinical Development in Immunology, you will provide scientific and strategic leadership while overseeing Early Development asset-specific programs within the Multiple Sclerosis and Immunology Development Unit (MSIDU). You will manage 2-5 programs, focusing on key goals such as First-in-Human, First-in-Patient, and Proof of Biology, with potential to evolve into pivotal global regulatory filings. This role reports to the Head of the MSIDU and involves managing a team of junior clinical development colleagues. Your work will be vital in maximizing the efficiency and effectiveness of our R&D organization, positioning Biogen as a leader in the field of immunology. By collaborating with research, biomarkers, and external innovation functions, your contributions will be integral to the successful transition from research to development.
What You’ll Do
- Provide accountability and primary oversight of the execution of multiple MSIDU portfolio drug assets
- Lead R2D activities from clinical perspective and ensure successful First-in-Human and First-in-Patient trials.
- Deliver scientific leadership across trial level DU activities in partnership with various functions.
- Represent Biogen’s Immunology DU in external collaborations and events.
- Hold primary relationships in internal and external scientific collaborations.
- Act as the Immunology DU representative in business development activities.
Who You Are
You are a visionary leader with a strong foundation in early clinical development and immunology. Your ability to navigate complex challenges with strategic insight makes you a valuable asset. You thrive in collaborative environments, leveraging your excellent communication skills to build strong relationships. Your passion for innovation drives you to excel in scientific leadership roles, and you are adept at managing and inspiring a team toward achieving ambitious goals.
Required Skills
- MD with significant clinical experience; clinical training in internal medicine is highly desired, and subspecialty training in Rheumatology or Dermatology preferred
- At least 10 years of clinical and clinical research experience.
- Minimum of 5 years of management experience and industry experience in clinical drug development.
- Extensive clinical or drug development experience in immunology conditions.
- Demonstrated leadership and team-building skills.
- Strategic and critical thinking in R2D transitions and Early Clinical Development.
- Excellent oral and written communication skills.
- Strong problem-solving, conflict resolution, and analytical skills.
Additional Information
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Top Skills
Biogen Cambridge, Massachusetts, USA Office
225 Binney Street, Cambridge, MA, United States, 02142
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
